Genenta Science S.P.A. ADR (GNTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,644 | -12,604 | -8,932 | -6,542 | -6,388 |
| Depreciation Amortization | 48 | 46 | 7 | 6 | 2 |
| Accounts payable and accrued liabilities | 35 | -788 | 1,058 | -432 | -20 |
| Other Working Capital | 1,858 | -452 | 253 | -2,300 | -1,052 |
| Other Operating Activity | 950 | 1,671 | -201 | 1,036 | 553 |
| Operating Cash Flow | $-6,753 | $-12,127 | $-7,816 | $-8,232 | $-6,905 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 7,453 | -16,103 | N/A | N/A | N/A |
| PPE Investments | -5 | -15 | -29 | -11 | -24 |
| Investing Cash Flow | $7,448 | $-16,118 | $-29 | $-11 | $-24 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 293 | 1 | N/A | 34,005 | 1,714 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -127 |
| Financing Cash Flow | $293 | $1 | $N/A | $34,005 | $1,587 |
| Exchange Rate Effect | -25 | -7 | N/A | N/A | N/A |
| Beginning Cash Position | 3,995 | 32,247 | 39,236 | 18,297 | 23,008 |
| End Cash Position | 4,958 | 3,995 | 31,392 | 44,059 | 17,666 |
| Net Cash Flow | $963 | $-28,252 | $-7,844 | $25,762 | $-5,342 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,753 | -12,127 | -7,816 | -8,232 | -6,905 |
| Capital Expenditure | -5 | -15 | -29 | -11 | -24 |
| Free Cash Flow | -6,757 | -12,142 | -7,844 | -8,243 | -6,929 |